RemedyRepack Inc. is recalling 9,038 vials of Lorazepam Injection (2mg/mL). The recall was initiated due to manufacturing deviations and the discontinuation of a quality program intended to ensure the drug meets standards for identity, strength, and purity. Because these safety checks were discontinued, the quality of the medication cannot be guaranteed. The product was distributed to three direct accounts in Pennsylvania.
The lack of an active quality program means the medication may not possess the correct strength or purity, potentially leading to ineffective treatment or safety issues for patients. No incidents or injuries have been reported to date.
Product originally manufactured by Akorn (Lake Forest, IL) and repackaged by RemedyRepack Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.